Absence of IFN-beta impairs antigen presentation capacity of splenic dendritic cells via down-regulation of heat shock protein 70.
about
Harnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting Cytokine Activity to Specific Cell TypesPolyinosinic-polycytidylic acid has therapeutic effects against cerebral ischemia/reperfusion injury through the downregulation of TLR4 signaling via TLR3Type I interferon is selectively required by dendritic cells for immune rejection of tumorsHigh affinity binding of hydrophobic and autoantigenic regions of proinsulin to the 70 kDa chaperone DnaK.Hsp70 and its molecular role in nervous system diseasesA systems biology approach to the analysis of subset-specific responses to lipopolysaccharide in dendritic cells.A temporal role of type I interferon signaling in CD8+ T cell maturation during acute West Nile virus infection.Scavenger receptor SREC-I mediated entry of TLR4 into lipid microdomains and triggered inflammatory cytokine release in RAW 264.7 cells upon LPS activationDiscovery of Intermediary Genes between Pathways Using Sparse Regression.IFNAR signaling directly modulates T lymphocyte activity, resulting in milder experimental autoimmune encephalomyelitis development.Type I interferons as regulators of human antigen presenting cell functions.Tumor-derived inducible heat-shock protein 70 (HSP70) is an essential component of anti-tumor immunity.Type I Interferons and Natural Killer Cell Regulation in Cancer.Beta interferon controls West Nile virus infection and pathogenesis in mice.Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer.The effects of chemotherapeutic drugs on human monocyte-derived dendritic cell differentiation and antigen presentation.
P2860
Q21131160-60F495A4-8D46-485D-B408-1E5DD942EFC0Q28238114-45F4A2EA-6844-4319-BC0D-AEE4B3E5E923Q28248500-8B6A7BAC-9E84-46C8-A554-03B3EF38089DQ33741151-A4C7E0DB-E9A6-4D90-BE2E-83F1AE38E925Q34170760-91313C8D-E694-4524-B88A-EEBB89127658Q35192110-ABEAFE76-B228-4ABC-BD7E-772191CEB36AQ35586915-430DEADD-4B60-47BB-8999-8B91D5399D8CQ35594232-B7DA99BF-8F7E-4ED0-9D69-53569FF5A1C2Q35766598-315784D9-C8C6-4298-A287-B20CE30D98ECQ36509839-6BA33B99-ABB0-445D-9217-8F0460BD6759Q38215320-FD9F92D8-D7AA-4DAD-AF7B-D2D6A3F506D0Q39012311-C62A5898-0BC5-453F-B7BC-98B6ABF657D5Q39241784-CBD173B4-A324-48C2-ABDE-E4DFD6E3E0B0Q42780413-CDCC2D22-DB81-4409-92B5-9D10B1D817E0Q47113436-ABD63FC8-9256-42E1-B9FF-0B5CEDFA8ED4Q51060472-C038AC04-7208-404E-9AA7-065D5FB84A42
P2860
Absence of IFN-beta impairs antigen presentation capacity of splenic dendritic cells via down-regulation of heat shock protein 70.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Absence of IFN-beta impairs an ...... tion of heat shock protein 70.
@en
Absence of IFN-beta impairs an ...... tion of heat shock protein 70.
@nl
type
label
Absence of IFN-beta impairs an ...... tion of heat shock protein 70.
@en
Absence of IFN-beta impairs an ...... tion of heat shock protein 70.
@nl
prefLabel
Absence of IFN-beta impairs an ...... tion of heat shock protein 70.
@en
Absence of IFN-beta impairs an ...... tion of heat shock protein 70.
@nl
P2093
P2860
P356
P1476
Absence of IFN-beta impairs an ...... tion of heat shock protein 70.
@en
P2093
Clayton R Hunt
Jacek Puchałka
Marcin Łyszkiewicz
Natalia Zietara
Nelson Gekara
Siegfried Weiss
Stefan Lienenklaus
Tej K Pandita
Vitor A P Martins Dos Santos
P2860
P304
P356
10.4049/JIMMUNOL.0803214
P407
P577
2009-07-01T00:00:00Z